Long non-coding RNA expression profiles predict clinical phenotypes in glioma
- PMID: 22709987
- DOI: 10.1016/j.nbd.2012.06.004
Long non-coding RNA expression profiles predict clinical phenotypes in glioma
Abstract
Glioma is the commonest form of primary brain tumor in adults with varying malignancy grades and histological subtypes. Long non-coding RNAs (lncRNAs) are a novel class of non-protein-coding transcripts that have been shown to play important roles in cancer development. To discover novel tumor-related lncRNAs and determine their associations with glioma subtypes, we first applied a lncRNA classification pipeline to identify 1970 lncRNAs that were represented on Affymetrix HG-U133 Plus 2.0 array. We then analyzed the lncRNA expression patterns in a set of previously published glioma gene expression profiles of 268 clinical specimens, and identified sets of lncRNAs that were unique to different histological subtypes (astrocytic versus oligodendroglial tumors) and malignancy grades. These lncRNAs signatures were then subject to validation in another non-overlapping, independent data set that contained 157 glioma samples. This is the first reported study that correlates lncRNA expression profiles with malignancy grade and histological differentiation in human gliomas. Our findings indicate the potential roles of lncRNAs in the biogenesis, development and differentiation of gliomas, and provide an important platform for future studies.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.Cancer Res. 2010 Dec 15;70(24):10060-70. doi: 10.1158/0008-5472.CAN-10-2465. Cancer Res. 2010. PMID: 21159630
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.Int J Oncol. 2012 Jun;40(6):2004-12. doi: 10.3892/ijo.2012.1413. Epub 2012 Mar 23. Int J Oncol. 2012. PMID: 22446686
-
Long non-coding RNAs in glioma: functional roles and clinical perspectives.Neurochem Int. 2014 Nov;77:78-85. doi: 10.1016/j.neuint.2014.05.008. Epub 2014 Jun 2. Neurochem Int. 2014. PMID: 24887176 Review.
-
Molecular pathways in the formation of gliomas.Glia. 1995 Nov;15(3):328-38. doi: 10.1002/glia.440150312. Glia. 1995. PMID: 8586467 Review.
Cited by
-
Potential of long non-coding RNAs as a therapeutic target and molecular markers in glioblastoma pathogenesis.Heliyon. 2021 Mar 15;7(3):e06502. doi: 10.1016/j.heliyon.2021.e06502. eCollection 2021 Mar. Heliyon. 2021. PMID: 33786397 Free PMC article. Review.
-
Long noncoding RNAs-related diseases, cancers, and drugs.ScientificWorldJournal. 2013 Jun 6;2013:943539. doi: 10.1155/2013/943539. Print 2013. ScientificWorldJournal. 2013. PMID: 23843741 Free PMC article. Review.
-
High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.J Exp Clin Cancer Res. 2016 May 6;35:75. doi: 10.1186/s13046-016-0352-9. J Exp Clin Cancer Res. 2016. PMID: 27154193 Free PMC article.
-
Immune-Related Long Non-coding RNA Signature and Clinical Nomogram to Evaluate Survival of Patients Suffering Esophageal Squamous Cell Carcinoma.Front Cell Dev Biol. 2021 Mar 4;9:641960. doi: 10.3389/fcell.2021.641960. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33748133 Free PMC article.
-
Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis.Front Oncol. 2020 Jul 24;10:1057. doi: 10.3389/fonc.2020.01057. eCollection 2020. Front Oncol. 2020. PMID: 32793467 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical